Literature DB >> 27750045

B-Lymphoblastic Lymphomas Evolving from Follicular Lymphomas Co-Express Surrogate Light Chains and Mutated Gamma Heavy Chains.

Linda M Slot1, Robbert Hoogeboom1, Laura A Smit2, Thera A M Wormhoudt1, Bart J Biemond3, Monique E C M Oud2, Esther J M Schilder-Tol2, André B Mulder4, Aldo Jongejan5, Antoine H C van Kampen6, Philip M Kluin7, Jeroen E J Guikema1, Richard J Bende1, Carel J M van Noesel8.   

Abstract

Follicular lymphoma (FL) is an indolent B-cell non-Hodgkin lymphoma able to transform into germinal center-type diffuse large B-cell lymphoma. We describe four extraordinary cases of FL, which progressed to TdT+CD20- precursor B-lymphoblastic lymphoma (B-LBL). Fluorescence in situ hybridization analysis showed that all four B-LBLs had acquired a MYC translocation on transformation. Comparative genomic hybridization analysis of one case demonstrated that in addition to 26 numerical aberrations that were shared between the FL and B-LBL, deletion of CDKN2A/B and 17q11, 14q32 amplification, and copy-neutral loss of heterozygosity of 9p were gained in the B-LBL cells. Whole-exome sequencing revealed mutations in FMN2, NEB, and SYNE1 and a nonsense mutation in KMT2D, all shared by the FL and B-LBL, and TNFRSF14, SMARCA2, CCND3 mutations uniquely present in the B-LBL. Remarkably, all four FL-B-LBL pairs expressed IgG. In two B-LBLs, evidence was obtained for ongoing rearrangement of IG light chain variable genes and expression of the surrogate light chain. IGHV mutation analysis showed that all FL-B-LBL pairs harbored identical or near-identical somatic mutations. From the somatic gene alterations found in the IG and non-IG genes, we conclude that the FLs and B-LBLs did not develop in parallel from early t(14;18)-positive IG-unmutated precursors, but that the B-LBLs developed from preexistent FL subclones that accumulated additional genetic damage.
Copyright © 2016 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27750045     DOI: 10.1016/j.ajpath.2016.07.027

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  7 in total

Review 1.  From genetics to the clinic: a translational perspective on follicular lymphoma.

Authors:  Sarah Huet; Pierre Sujobert; Gilles Salles
Journal:  Nat Rev Cancer       Date:  2018-02-09       Impact factor: 60.716

2.  Mantle cell lymphomas with concomitant MYC and CCND1 breakpoints are recurrently TdT positive and frequently show high-grade pathological and genetic features.

Authors:  Sietse M Aukema; Giorgio A Croci; Reiner Siebert; Wolfram Klapper; Susanne Bens; Kathrin Oehl-Huber; Rabea Wagener; German Ott; Andreas Rosenwald; Philip M Kluin; Eva van den Berg; Anneke G Bosga-Bouwer; Mels Hoogendoorn; Eva Hoster; Iris Bittmann; Inga Nagel; Eva M Murga Penas; Markus Kreuz; Julia Bausinger; Wilfried Belder; Ilske Oschlies; Martin J S Dyer; Sandrine Jayne
Journal:  Virchows Arch       Date:  2021-02-02       Impact factor: 4.064

3.  IG-MYC + neoplasms with precursor B-cell phenotype are molecularly distinct from Burkitt lymphomas.

Authors:  Rabea Wagener; Cristina López; Kortine Kleinheinz; Julia Bausinger; Sietse M Aukema; Inga Nagel; Umut H Toprak; Julian Seufert; Janine Altmüller; Holger Thiele; Christof Schneider; Julia Kolarova; Jeongbin Park; Daniel Hübschmann; Eva M Murga Penas; Hans G Drexler; Andishe Attarbaschi; Randi Hovland; Eigil Kjeldsen; Michael Kneba; Udo Kontny; Laurence de Leval; Peter Nürnberg; Ilske Oschlies; David Oscier; Brigitte Schlegelberger; Stephan Stilgenbauer; Wilhelm Wössmann; Matthias Schlesner; Birgit Burkhardt; Wolfram Klapper; Elaine S Jaffe; Ralf Küppers; Reiner Siebert
Journal:  Blood       Date:  2018-10-03       Impact factor: 22.113

4.  Transformation of a low-grade follicular lymphoma into a composite lymphoma combining a high-grade B-cell lymphoma and a lymphoblastic neoplasm expressing Terminal deoxynucleotidyl Transferase: a case report.

Authors:  Antonin Bouroumeau; Eleonore Kaphan; Clémentine Legrand; Tatiana Raskovalova; Gautier Szymanski; Claire Vettier; Christine Lefebvre; Marie-Christine Jacob; Anne McLeer; Michel Peuchmaur; Rémy Gressin; Hervé Sartelet
Journal:  J Med Case Rep       Date:  2020-07-27

5.  Dramatic increase in gene mutational burden after transformation of follicular lymphoma into TdT+ B-lymphoblastic leukemia/lymphoma.

Authors:  Jonathan P Belman; Wenzhao Meng; Hong Yi Wang; Jie Li; Honore T Strauser; Aaron M Rosenfeld; Qian Zhang; Eline T Luning Prak; Mariusz Wasik
Journal:  Cold Spring Harb Mol Case Stud       Date:  2020-02-03

6.  A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma: a retrospective training and validation analysis in three international cohorts.

Authors:  Sarah Huet; Bruno Tesson; Jean-Philippe Jais; Andrew L Feldman; Laura Magnano; Emilie Thomas; Alexandra Traverse-Glehen; Benoit Albaud; Marjorie Carrère; Luc Xerri; Stephen M Ansell; Lucile Baseggio; Cécile Reyes; Karin Tarte; Sandrine Boyault; Corinne Haioun; Brian K Link; Pierre Feugier; Armando Lopez-Guillermo; Hervé Tilly; Pauline Brice; Sandrine Hayette; Fabrice Jardin; Fritz Offner; Pierre Sujobert; David Gentien; Alain Viari; Elias Campo; James R Cerhan; Gilles Salles
Journal:  Lancet Oncol       Date:  2018-02-20       Impact factor: 41.316

7.  "Double hit" B-lymphoblastic lymphoma with concurrent IGH/BCL2 and 8q24/MYC translocations: a case report.

Authors:  Lu He; Zhiwen Li; Xiangshan Fan; Jieyu Chen; Hongyan Wu; Yao Fu
Journal:  Transl Cancer Res       Date:  2021-03       Impact factor: 1.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.